57 related articles for article (PubMed ID: 29871973)
1. Gut microbial metabolite TMAO increases peritoneal inflammation and peritonitis risk in peritoneal dialysis patients.
Zhang L; Xie F; Tang H; Zhang X; Hu J; Zhong X; Gong N; Lai Y; Zhou M; Tian J; Zhou Z; Xie L; Hu Z; Zhu F; Jiang J; Nie J
Transl Res; 2022 Feb; 240():50-63. PubMed ID: 34673277
[TBL] [Abstract][Full Text] [Related]
2. Complement terminal pathway inhibition reduces peritoneal injuries in a rat peritonitis model.
Kamegai N; Kim H; Suzuki Y; Fukui S; Kojima H; Maruyama S; Morgan BP; Zelek WM; Mizuno M
Clin Exp Immunol; 2023 Dec; 214(2):209-218. PubMed ID: 37549240
[TBL] [Abstract][Full Text] [Related]
3. Intra-Abdominal Lipopolysaccharide Clearance and Inactivation in Peritonitis: Key Roles for Lipoproteins and the Phospholipid Transfer Protein.
Nguyen M; Pallot G; Jalil A; Tavernier A; Dusuel A; Le Guern N; Lagrost L; Pais de Barros JP; Choubley H; Bergas V; Guinot PG; Masson D; Bouhemad B; Gautier T
Front Immunol; 2021; 12():622935. PubMed ID: 34054798
[TBL] [Abstract][Full Text] [Related]
4. Effect of aquaporin 1 on mouse peritoneal mesothelial cells after a long-term peritoneal dialysis.
Wang J; Wang Y; Lou Y; Cui W; Zhang Y; Dong W; Sun J; Miao L
Ther Apher Dial; 2021 Feb; 25(1):88-96. PubMed ID: 32311233
[TBL] [Abstract][Full Text] [Related]
5. Exploring the Role of Cell-Free Nucleic Acids and Peritoneal Dialysis: A Narrative Review.
Morisi N; Virzì GM; Ferrarini M; Alfano G; Zanella M; Ronco C; Donati G
Genes (Basel); 2024 Apr; 15(5):. PubMed ID: 38790182
[TBL] [Abstract][Full Text] [Related]
6. Sterile inflammation of peritoneal membrane caused by peritoneal dialysis: focus on the communication between immune cells and peritoneal stroma.
Su H; Zou R; Su J; Chen X; Yang H; An N; Yang C; Tang J; Liu H; Yao C
Front Immunol; 2024; 15():1387292. PubMed ID: 38779674
[TBL] [Abstract][Full Text] [Related]
7. Rosiglitazone alleviates LPS-induced endometritis via suppression of TLR4-mediated NF-κB activation.
Bao H; Cong J; Qu Q; He S; Zhao D; Zhao H; Yin S; Ma D
PLoS One; 2024; 19(3):e0280372. PubMed ID: 38547218
[TBL] [Abstract][Full Text] [Related]
8. Autophagy in peritoneal fibrosis.
Su HY; Yang JJ; Zou R; An N; Chen XC; Yang C; Yang HJ; Yao CW; Liu HF
Front Physiol; 2023; 14():1187207. PubMed ID: 37256065
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol ameliorates the behavioural and molecular changes in rats exposed to uninephrectomy: role of hippocampal SIRT1, BDNF and AChE.
Basta M; Saleh SR; Aly RG; Dief AE
J Physiol Biochem; 2023 May; 79(2):273-285. PubMed ID: 36469209
[TBL] [Abstract][Full Text] [Related]
10. Lipopolysaccharide-induced inflammation in human peritoneal mesothelial cells is controlled by ERK1/2-CDK5-PPARγ axis.
Li Z; Feng J; Yang S; Meng P; Li J; Li H; Gao X; Zhang Y
Ann Transl Med; 2021 May; 9(10):850. PubMed ID: 34164484
[TBL] [Abstract][Full Text] [Related]
11. IL-17A as a Potential Therapeutic Target for Patients on Peritoneal Dialysis.
Marchant V; Tejera-Muñoz A; Marquez-Expósito L; Rayego-Mateos S; Rodrigues-Diez RR; Tejedor L; Santos-Sanchez L; Egido J; Ortiz A; Valdivielso JM; Fraser DJ; López-Cabrera M; Selgas R; Ruiz-Ortega M
Biomolecules; 2020 Sep; 10(10):. PubMed ID: 32987705
[TBL] [Abstract][Full Text] [Related]
12. Role of rosiglitazone in lipopolysaccharide-induced peritonitis: a rat peritoneal dialysis model.
Song SH; Kwak IS; Yang BY; Lee DW; Lee SB; Lee MY
Nephrology (Carlton); 2009 Apr; 14(2):155-63. PubMed ID: 19207869
[TBL] [Abstract][Full Text] [Related]
13. PPAR-γ agonist rosiglitazone protects peritoneal membrane from dialysis fluid-induced damage.
Sandoval P; Loureiro J; González-Mateo G; Pérez-Lozano ML; Maldonado-Rodríguez A; Sánchez-Tomero JA; Mendoza L; Santamaría B; Ortiz A; Ruíz-Ortega M; Selgas R; Martín P; Sánchez-Madrid F; Aguilera A; López-Cabrera M
Lab Invest; 2010 Oct; 90(10):1517-32. PubMed ID: 20531289
[TBL] [Abstract][Full Text] [Related]
14. Histomorphological and functional changes of the peritoneal membrane during long-term peritoneal dialysis.
Fusshoeller A
Pediatr Nephrol; 2008 Jan; 23(1):19-25. PubMed ID: 17638023
[TBL] [Abstract][Full Text] [Related]
15. Proteomic Research in Peritoneal Dialysis.
Bonomini M; Borras FE; Troya-Saborido M; Carreras-Planella L; Di Liberato L; Arduini A
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32752018
[TBL] [Abstract][Full Text] [Related]
16. PPAR-γ agonist rosiglitazone ameliorates peritoneal deterioration in peritoneal dialysis rats with LPS-induced peritonitis through up-regulation of AQP-1 and ZO-1.
Zhang Y; Feng J; Wang Q; Zhao S; Xu J; Li H
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29871973
[TBL] [Abstract][Full Text] [Related]
17. Rosiglitazone, a Peroxisome Proliferator-Activated Receptor (PPAR)-γ Agonist, Attenuates Inflammation Via NF-κB Inhibition in Lipopolysaccharide-Induced Peritonitis.
Zhang YF; Zou XL; Wu J; Yu XQ; Yang X
Inflammation; 2015 Dec; 38(6):2105-15. PubMed ID: 26047949
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
